Home  >  Products  >  B4GALT3 (UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3) Blocking Peptide (the N terminal of B4GALT3)(100ug)
B4GALT3 (UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3) Blocking Peptide (the N terminal of B4GALT3)(100ug)

B4GALT3 (UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3) Blocking Peptide (the N terminal of B4GALT3)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-B4GALT3 Antibody(ARP45532_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP45532
Size: 100ug
Weight: 44kDa
Gene: 8703
Format: Lyophilized powder
Target: B4GALT3 is an enzyme that may be mainly involved in the synthesis of the first N-acetyllactosamine unit of poly-N-acetyllactosamine chains.
Alternative names: beta4Gal-T3
See Full Product Listings >